Cosmos Health (COSM) vs Cellyan Biotechnology (HKPD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Cosmos Health is the larger company by market cap ($34.6 million vs $5.2 million), about 6.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COSM | HKPD |
|---|---|---|
| Share price | $0.3439 | $0.105 |
| Market cap | $34.61M | $5.18M |
| 1-day change | +9.38% | +4.17% |
| YTD return | -36.87% | — |
| 1-year return | -70.34% | — |
| 5-year return | -92.62% | — |
| Forward P/E | 4.91 | — |
| EPS (TTM) | $-0.65 | $-0.07 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.32 | $1.72 |
| 52-week low | $0.162 | $0.095 |
| Distance from 52-week high | -73.95% | -93.89% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +1208.52% | — |
| Average volume | 4.20M | 3.78M |
| Shares outstanding | 100.63M | 42.17M |
| Employees | 163 | 11 |
| Sector | Health Care | Health Care |
| Industry | Other Pharmaceuticals | Other Pharmaceuticals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cosmos Health is about 6.7 times larger than Cellyan Biotechnology by market value ($34.61M vs $5.18M).
About Cosmos Health
COSM stock →Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus.
Health Care · Other Pharmaceuticals · 163 employees
About Cellyan Biotechnology
HKPD stock →Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services.
Health Care · Other Pharmaceuticals · 11 employees
COSM vs HKPD FAQ
Which is bigger, Cosmos Health or Cellyan Biotechnology?
Cosmos Health (COSM) is larger, with a market capitalization of $34.61M compared with $5.18M for Cellyan Biotechnology (HKPD).
Are Cosmos Health and Cellyan Biotechnology in the same industry?
Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.